Skip to content
NEWSnet Santa Barbara
    • Homepage
NIAID Awards Zepto Life Technology Contract Valued at Up to $8.9 Million to Advance the First Deployable Liquid Biopsy Platform for Infectious Disease

Author: Zepto Life Technology

Posted Date:

August 11, 2026
  • NIAID Awards Zepto Life Technology Contract Valued at Up to $8.9 Million to Advance the First Deployable Liquid Biopsy Platform for Infectious Disease

    Zepto Life Technology
    August 11, 2026
  • Zepto Life Technology Introduces FungiFlex® Pneumocystis jirovecii and FungiFlex® Mold Plus

    Zepto Life Technology
    July 15, 2026